Dr. Adalja is a Senior Scholar at the Johns Hopkins Center for Health Security, an Adjunct Assistant Professor at the Johns Hopkins Bloomberg School of Public Health, and an Affiliate of the Johns Hopkins Center for Global Health. His work is focused on emerging infectious disease, pandemic preparedness, and biosecurity. Dr. Adalja has served on US government panels tasked with developing guidelines for the treatment of plague, botulism, and anthrax in mass casualty settings and for the system of care for infectious disease emergencies. During the pandemic, Dr. Adalja has served as a member of the National Collegiate Athletic Association coronavirus advisory group; a consultant to various businesses, schools, and organizations; and an informal advisor to the International Monetary Fund.